- Combination antiviral/mAb trials through RECOVER-TLC or Polybio
- More findings from the various European ME/CFS programs, esp Rob Wüst's group
- Progress towards replicable biomarkers of viral persistence in LC
- Combination antiviral/mAb trials through RECOVER-TLC or Polybio
- More findings from the various European ME/CFS programs, esp Rob Wüst's group
- Progress towards replicable biomarkers of viral persistence in LC